Global Etanercept Sales Market Report 2024
Market Analysis and InsightsGlobal Etanercept Market
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis.
Due to the COVID-19 pandemic, the global Etanercept market size is estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Benepali accounting for % of the Etanercept global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Arthritis segment is altered to an % CAGR throughout this forecast period.
The production of TNF in the body causes inflammation, pain, and damage to the bones and joints. Etanercept blocks the action of TNF and reduces the inflammation. It is prescribed to treat juvenile rheumatoid arthritis, rheumatoid arthritis, and psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis.
Global Etanercept Scope and Market Size
The global Etanercept market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Etanercept market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Benepali
Enbrel
Others
Segment by Application
Arthritis
Psoriasis
Spondylitis
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Amgen
Pfizer
Takeda
Sanofi
GlaxoSmithKline
Sandoz
Celltrion
Dexa Medica
Bionovis
Momenta Pharmaceuticals
HanAll Biopharma
MedImmune
Tsumura
Table of Content
1 Etanercept Market Overview
1.1 Etanercept Product Scope
1.2 Etanercept Segment by Type
1.2.1 Global Etanercept Sales by Type (2018 & 2024 & 2034)
1.2.2 Benepali
1.2.3 Enbrel
1.2.4 Others
1.3 Etanercept Segment by Application
1.3.1 Global Etanercept Sales Comparison by Application (2018 & 2024 & 2034)
1.3.2 Arthritis
1.3.3 Psoriasis
1.3.4 Spondylitis
1.3.5 Others
1.4 Etanercept Market Estimates and Forecasts (2018-2034)
1.4.1 Global Etanercept Market Size in Value Growth Rate (2018-2034)
1.4.2 Global Etanercept Market Size in Volume Growth Rate (2018-2034)
1.4.3 Global Etanercept Price Trends (2018-2034)
2 Etanercept Estimates and Forecasts by Region
2.1 Global Etanercept Market Size by Region: 2018 VS 2024 VS 2034
2.2 Global Etanercept Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Etanercept Sales Market Share by Region (2018-2023)
2.2.2 Global Etanercept Revenue Market Share by Region (2018-2023)
2.3 Global Etanercept Market Estimates and Forecasts by Region (2024-2034)
2.3.1 Global Etanercept Sales Estimates and Forecasts by Region (2024-2034)
2.3.2 Global Etanercept Revenue Forecast by Region (2024-2034)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Etanercept Estimates and Projections (2018-2034)
2.4.2 Europe Etanercept Estimates and Projections (2018-2034)
2.4.3 China Etanercept Estimates and Projections (2018-2034)
2.4.4 Japan Etanercept Estimates and Projections (2018-2034)
2.4.5 Southeast Asia Etanercept Estimates and Projections (2018-2034)
2.4.6 India Etanercept Estimates and Projections (2018-2034)
3 Global Etanercept Competition Landscape by Players
3.1 Global Top Etanercept Players by Sales (2018-2023)
3.2 Global Top Etanercept Players by Revenue (2018-2023)
3.3 Global Etanercept Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Etanercept as of 2024)
3.4 Global Etanercept Average Price by Company (2018-2023)
3.5 Manufacturers Etanercept Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Etanercept Market Size by Type
4.1 Global Etanercept Historic Market Review by Type (2018-2023)
4.1.1 Global Etanercept Sales by Type (2018-2023)
4.1.2 Global Etanercept Revenue by Type (2018-2023)
4.1.3 Global Etanercept Price by Type (2018-2023)
4.2 Global Etanercept Market Estimates and Forecasts by Type (2024-2034)
4.2.1 Global Etanercept Sales Forecast by Type (2024-2034)
4.2.2 Global Etanercept Revenue Forecast by Type (2024-2034)
4.2.3 Global Etanercept Price Forecast by Type (2024-2034)
5 Global Etanercept Market Size by Application
5.1 Global Etanercept Historic Market Review by Application (2018-2023)
5.1.1 Global Etanercept Sales by Application (2018-2023)
5.1.2 Global Etanercept Revenue by Application (2018-2023)
5.1.3 Global Etanercept Price by Application (2018-2023)
5.2 Global Etanercept Market Estimates and Forecasts by Application (2024-2034)
5.2.1 Global Etanercept Sales Forecast by Application (2024-2034)
5.2.2 Global Etanercept Revenue Forecast by Application (2024-2034)
5.2.3 Global Etanercept Price Forecast by Application (2024-2034)
6 United States Etanercept Market Facts & Figures
6.1 United States Etanercept Sales by Company
6.1.1 United States Etanercept Sales by Company (2018-2023)
6.1.2 United States Etanercept Revenue by Company (2018-2023)
6.2 United States Etanercept Sales Breakdown by Type
6.2.1 United States Etanercept Sales Breakdown by Type (2018-2023)
6.2.2 United States Etanercept Sales Breakdown by Type (2024-2034)
6.3 United States Etanercept Sales Breakdown by Application
6.3.1 United States Etanercept Sales Breakdown by Application (2018-2023)
6.3.2 United States Etanercept Sales Breakdown by Application (2024-2034)
7 Europe Etanercept Market Facts & Figures
7.1 Europe Etanercept Sales by Company
7.1.1 Europe Etanercept Sales by Company (2018-2023)
7.1.2 Europe Etanercept Revenue by Company (2018-2023)
7.2 Europe Etanercept Sales Breakdown by Type
7.2.1 Europe Etanercept Sales Breakdown by Type (2018-2023)
7.2.2 Europe Etanercept Sales Breakdown by Type (2024-2034)
7.3 Europe Etanercept Sales Breakdown by Application
7.3.1 Europe Etanercept Sales Breakdown by Application (2018-2023)
7.3.2 Europe Etanercept Sales Breakdown by Application (2024-2034)
8 China Etanercept Market Facts & Figures
8.1 China Etanercept Sales by Company
8.1.1 China Etanercept Sales by Company (2018-2023)
8.1.2 China Etanercept Revenue by Company (2018-2023)
8.2 China Etanercept Sales Breakdown by Type
8.2.1 China Etanercept Sales Breakdown by Type (2018-2023)
8.2.2 China Etanercept Sales Breakdown by Type (2024-2034)
8.3 China Etanercept Sales Breakdown by Application
8.3.1 China Etanercept Sales Breakdown by Application (2018-2023)
8.3.2 China Etanercept Sales Breakdown by Application (2024-2034)
9 Japan Etanercept Market Facts & Figures
9.1 Japan Etanercept Sales by Company
9.1.1 Japan Etanercept Sales by Company (2018-2023)
9.1.2 Japan Etanercept Revenue by Company (2018-2023)
9.2 Japan Etanercept Sales Breakdown by Type
9.2.1 Japan Etanercept Sales Breakdown by Type (2018-2023)
9.2.2 Japan Etanercept Sales Breakdown by Type (2024-2034)
9.3 Japan Etanercept Sales Breakdown by Application
9.3.1 Japan Etanercept Sales Breakdown by Application (2018-2023)
9.3.2 Japan Etanercept Sales Breakdown by Application (2024-2034)
10 Southeast Asia Etanercept Market Facts & Figures
10.1 Southeast Asia Etanercept Sales by Company
10.1.1 Southeast Asia Etanercept Sales by Company (2018-2023)
10.1.2 Southeast Asia Etanercept Revenue by Company (2018-2023)
10.2 Southeast Asia Etanercept Sales Breakdown by Type
10.2.1 Southeast Asia Etanercept Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Etanercept Sales Breakdown by Type (2024-2034)
10.3 Southeast Asia Etanercept Sales Breakdown by Application
10.3.1 Southeast Asia Etanercept Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Etanercept Sales Breakdown by Application (2024-2034)
11 India Etanercept Market Facts & Figures
11.1 India Etanercept Sales by Company
11.1.1 India Etanercept Sales by Company (2018-2023)
11.1.2 India Etanercept Revenue by Company (2018-2023)
11.2 India Etanercept Sales Breakdown by Type
11.2.1 India Etanercept Sales Breakdown by Type (2018-2023)
11.2.2 India Etanercept Sales Breakdown by Type (2024-2034)
11.3 India Etanercept Sales Breakdown by Application
11.3.1 India Etanercept Sales Breakdown by Application (2018-2023)
11.3.2 India Etanercept Sales Breakdown by Application (2024-2034)
12 Company Profiles and Key Figures in Etanercept Business
12.1 Amgen
12.1.1 Amgen Corporation Information
12.1.2 Amgen Business Overview
12.1.3 Amgen Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Amgen Etanercept Products Offered
12.1.5 Amgen Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Pfizer Etanercept Products Offered
12.2.5 Pfizer Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Business Overview
12.3.3 Takeda Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Takeda Etanercept Products Offered
12.3.5 Takeda Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Business Overview
12.4.3 Sanofi Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Sanofi Etanercept Products Offered
12.4.5 Sanofi Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Business Overview
12.5.3 GlaxoSmithKline Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.5.4 GlaxoSmithKline Etanercept Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Sandoz
12.6.1 Sandoz Corporation Information
12.6.2 Sandoz Business Overview
12.6.3 Sandoz Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Sandoz Etanercept Products Offered
12.6.5 Sandoz Recent Development
12.7 Celltrion
12.7.1 Celltrion Corporation Information
12.7.2 Celltrion Business Overview
12.7.3 Celltrion Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Celltrion Etanercept Products Offered
12.7.5 Celltrion Recent Development
12.8 Dexa Medica
12.8.1 Dexa Medica Corporation Information
12.8.2 Dexa Medica Business Overview
12.8.3 Dexa Medica Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.8.4 Dexa Medica Etanercept Products Offered
12.8.5 Dexa Medica Recent Development
12.9 Bionovis
12.9.1 Bionovis Corporation Information
12.9.2 Bionovis Business Overview
12.9.3 Bionovis Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.9.4 Bionovis Etanercept Products Offered
12.9.5 Bionovis Recent Development
12.10 Momenta Pharmaceuticals
12.10.1 Momenta Pharmaceuticals Corporation Information
12.10.2 Momenta Pharmaceuticals Business Overview
12.10.3 Momenta Pharmaceuticals Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.10.4 Momenta Pharmaceuticals Etanercept Products Offered
12.10.5 Momenta Pharmaceuticals Recent Development
12.11 HanAll Biopharma
12.11.1 HanAll Biopharma Corporation Information
12.11.2 HanAll Biopharma Business Overview
12.11.3 HanAll Biopharma Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.11.4 HanAll Biopharma Etanercept Products Offered
12.11.5 HanAll Biopharma Recent Development
12.12 MedImmune
12.12.1 MedImmune Corporation Information
12.12.2 MedImmune Business Overview
12.12.3 MedImmune Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.12.4 MedImmune Etanercept Products Offered
12.12.5 MedImmune Recent Development
12.13 Tsumura
12.13.1 Tsumura Corporation Information
12.13.2 Tsumura Business Overview
12.13.3 Tsumura Etanercept Sales, Revenue and Gross Margin (2018-2023)
12.13.4 Tsumura Etanercept Products Offered
12.13.5 Tsumura Recent Development
13 Etanercept Manufacturing Cost Analysis
13.1 Etanercept Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Etanercept
13.4 Etanercept Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Etanercept Distributors List
14.3 Etanercept Customers
15 Market Dynamics
15.1 Etanercept Industry Trends
15.2 Etanercept Market Drivers
15.3 Etanercept Market Challenges
15.4 Etanercept Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer